Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idarubicin Dose Intensification in AML
NCT01518556Phase 2Completed
- Sponsor
- Konkuk University Medical Center
- Start
- Jul 2011
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of idarubicin in acute myeloid leukemia (AML), sponsored by Konkuk University Medical Center. Started Jul 2011; status: completed.
02
Drugs
idarubicin
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01518556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01518556.